Capital Wealth Planning’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.89M | Buy |
84,314
+23,200
| +38% | +$1.62M | 0.05% | 56 |
|
|
2025
Q1 | $4.49M | Buy |
61,114
+15,312
| +33% | +$1.13M | 0.04% | 50 |
|
|
2024
Q4 | $3M | Sell |
45,802
-2,820
| -6% | -$185K | 0.03% | 63 |
|
|
2024
Q3 | $3.79M | Buy |
48,622
+22,341
| +85% | +$1.74M | 0.04% | 50 |
|
|
2024
Q2 | $2.05M | Buy |
26,281
+18,101
| +221% | +$1.41M | 0.02% | 74 |
|
|
2024
Q1 | $554K | Sell |
8,180
-3,768
| -32% | -$255K | 0.01% | 106 |
|
|
2023
Q4 | $805K | Buy |
11,948
+1,848
| +18% | +$124K | 0.01% | 92 |
|
|
2023
Q3 | $684K | Buy |
10,100
+4,960
| +96% | +$336K | 0.01% | 82 |
|
|
2023
Q2 | $368K | Buy |
5,140
+1,510
| +42% | +$108K | ﹤0.01% | 110 |
|
|
2023
Q1 | $252K | Buy |
+3,630
| New | +$252K | ﹤0.01% | 124 |
|